* Definitive Healthcare Corp DH.OQ DH.O is expected
to show a
rise in quarterly revenue when it reports results on February
23.
* The Framingham Massachusetts-based company is expected to
report a 26.2% increase in revenue to $58.454 million from
$46.31 million a year ago, according to the mean estimate from
12 analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Definitive
Healthcare
Corp is for earnings of 4 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 7
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Definitive
Healthcare Corp is $15, above its last closing price
of $12.28.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Sep. 30 2022 0.05 0.05 0.06 Beat 27.7
Jun. 30 2022 0.05 0.05 0.06 Beat 18.3
Mar. 31 2022 0.03 0.03 0.05 Beat 44.9
Dec. 31 2021 0.04 0.04 0.04 Met -7.4
Sep. 0.02 0.02 0.01 Missed -47.4
30 2021
This summary was machine generated February 21 at 21:36 GMT.
All figures in US dollars unless otherwise stated